Skip to content

Pain Avoidance Behavior and Its Relation to Risk for Opioid Use in Chronic Pain Patients

CompletedNot applicableNCT04603417
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

This study is designed to find behavioral and neurophysiological correlates of pain avoidance behavior among chronic pain patients, controlling for risk for opioid use disorder. Further, traits and risk factors that contribute to pain avoidance behavior will be investigated. The knowledge gained will broaden the current understanding of mechanisms involved in pain avoidance behavior in chronic pain patients, and help devise novel interventions.

Study details

Official title
Pain Avoidance Behavior and Its Relation to Risk for Opioid Use in Chronic Pain Patients
Interventions
  • Diagnostic test: Electroencephalography (EEG)/Magnetoencephalography (MEG)/MRI
Sponsor
The Cleveland Clinic
Collaborators
National Institute on Drug Abuse (NIDA)
Start date
2020-08-15
Primary completion
2024-04-30
Sex
All
Age range
from 18 Years
Healthy volunteers
true
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 18 years and older * Diagnosis of CRPS I, CRPS II * Six months or more of medically refractory severe pain * Average daily pain for the past 30 days reported as ≥ 5 on a 0 - 10 scale * Presence of allodynia * Unilateral pain or pain affecting predominantly one extremity. Predominantly will be operationally defined at \>=75 of pain on one extremity. * Willingness to complete behavioral, clinical and neurophysiological measurement procedures * Able to provide informed consent * Able to undergo structural brain MRI Exclusion Criteria: * 17 years and younger * All other pain diagnosis * Less than six months or more of medically refractory severe pain * Average daily pain for the past 30 days reported as \< 5 on a 0 - 10 scale * Absence of allodynia * Bilateral pain * Unwillingness to complete behavioral, clinical and neurophysiological measurement procedures * Unable to provide informed consent * Claustrophobic or unable to undergo MRI, MEG or unsafe to undergo MRI (i.e. due to MRI unsafe medical implants).

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04603417